Browse treatments

…VC was normal. Treatment with oral methotrexate 10mg weekly and vasodilator therapy resulted in mild clinical improvement despite poor therapeutic …

…luate changes of serum level of IL-4 in patient with SSc during immunosuppressive therapy.Material and Methods There were 83 patients with SSc included i…

…olism were observed, likely reflecting the higher prevalence of anti-rheumatic treatment among patients with SSc-ILD.Abstract P.224 Figure 1Abstract P.2…

…hort, as well as to capture potential correlations with type of immunosuppressive treatment.Material and Methods We selected 21 patients from 2 Dutch centr…

…tial to enhance patient management and guide the development of targeted therapies.Abstract P.245 Table 1Abstract P.245 Figure 1Kaplan-Meier curve…

…Introduction CAR T-cell therapy targeting CD19 has shown potential in autoimmune diseases such …

…ers, and the other one showed improvement.All patients required vasodilator therapy before HSCT; after transplantation, only one patient continued …

…Introduction Chimeric antigen receptor T-cell (CAR-T) therapy is emerging as a novel approach for systemic sclerosis (SSc). W…

…lophosphamide. However, 10–20% of patients relapse after AHSCT. Chimeric Antigen Receptor T-cell (CAR-T) therapy is a promising treatment for SSc but has not been evaluated as …

…sponses. For patients with severe, rapidly progressive disease, autologous hematopoietic stem cell transplantation (HSCT) has emerged as an effective therapeutic option, despite …

…i-topoisomerase-1 antibodies (a-topo-1) in patients with SSc on RTX therapy.Material and Methods In this study we prospectively included 48…

…cers, and calcinosis, impairing daily life and quality of life. Conventional therapies often require face-to-face care. This study evaluates a telehea…